Solid Biosciences Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Solid Biosciences Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Solid Biosciences Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $107M.
  • Solid Biosciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.12M, a 95.8% decline from 2022.
  • Solid Biosciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $74.8M, a 44.6% decline from 2021.
  • Solid Biosciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $135M, a 4.88% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.12M -$71.7M -95.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $74.8M -$60.2M -44.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $135M +$6.29M +4.88% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-13
2020 $129M +$70.8M +122% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $57.9M -$73.6M -56% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
2018 $132M +$54.4M +70.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $77.1M +$73.7M +2154% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $3.42M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.